IRIS
VIDILI, Gianpaolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.294
AS - Asia 2.820
SA - Sud America 1.676
EU - Europa 1.434
Continente sconosciuto - Info sul continente non disponibili 161
AF - Africa 115
OC - Oceania 13
Totale 10.513
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.163
BR - Brasile 1.488
SG - Singapore 1.259
CN - Cina 688
IT - Italia 313
UA - Ucraina 311
VN - Vietnam 226
HK - Hong Kong 198
DE - Germania 177
FR - Francia 130
SE - Svezia 91
FI - Finlandia 88
GB - Regno Unito 88
RU - Federazione Russa 73
BD - Bangladesh 69
AR - Argentina 65
CA - Canada 51
IN - India 50
TR - Turchia 50
IQ - Iraq 49
MX - Messico 41
EC - Ecuador 33
ID - Indonesia 33
ZA - Sudafrica 31
MA - Marocco 30
UZ - Uzbekistan 28
CO - Colombia 24
JP - Giappone 24
PL - Polonia 24
VE - Venezuela 22
PK - Pakistan 21
BE - Belgio 17
AT - Austria 16
CZ - Repubblica Ceca 16
ES - Italia 16
KR - Corea 16
NL - Olanda 14
RO - Romania 14
AU - Australia 12
KE - Kenya 12
JO - Giordania 11
AE - Emirati Arabi Uniti 10
CL - Cile 10
JM - Giamaica 10
PY - Paraguay 10
UY - Uruguay 10
CI - Costa d'Avorio 9
LT - Lituania 9
SA - Arabia Saudita 9
AL - Albania 8
AZ - Azerbaigian 8
BO - Bolivia 8
HN - Honduras 7
LB - Libano 7
NP - Nepal 7
TN - Tunisia 7
CR - Costa Rica 6
IL - Israele 6
KZ - Kazakistan 6
PE - Perù 6
DO - Repubblica Dominicana 5
EG - Egitto 5
MY - Malesia 5
OM - Oman 5
BN - Brunei Darussalam 4
CH - Svizzera 4
DZ - Algeria 4
IR - Iran 4
KG - Kirghizistan 4
SN - Senegal 4
BH - Bahrain 3
EE - Estonia 3
KW - Kuwait 3
MN - Mongolia 3
NG - Nigeria 3
PA - Panama 3
RS - Serbia 3
XK - ???statistics.table.value.countryCode.XK??? 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BS - Bahamas 2
CY - Cipro 2
ET - Etiopia 2
GE - Georgia 2
IE - Irlanda 2
LV - Lettonia 2
NI - Nicaragua 2
PH - Filippine 2
PT - Portogallo 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TG - Togo 2
AG - Antigua e Barbuda 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BT - Bhutan 1
BW - Botswana 1
BY - Bielorussia 1
EU - Europa 1
Totale 10.339
Salva come PNG Salva come JPEG
Città #
Dallas 1.288
Singapore 655
Chandler 420
San Jose 373
Ashburn 255
Hong Kong 193
Beijing 190
Jacksonville 178
Princeton 147
Council Bluffs 122
Columbus 109
São Paulo 108
Lauterbourg 86
Nanjing 82
Ho Chi Minh City 78
Sassari 72
Dearborn 69
Santa Clara 61
Ann Arbor 57
Shanghai 57
Los Angeles 56
New York 55
Hanoi 54
Belo Horizonte 53
Rio de Janeiro 53
Helsinki 48
Wilmington 44
Boardman 30
Moscow 30
Brasília 28
Nanchang 28
Shenyang 26
Tashkent 25
Orem 24
Curitiba 23
Munich 23
Tokyo 23
Tianjin 21
Woodbridge 21
Nuremberg 20
Porto Alegre 20
Warsaw 20
Frankfurt am Main 19
Milan 19
Atlanta 18
Brooklyn 18
Changsha 17
Brno 16
Houston 16
Johannesburg 16
Toronto 16
Brussels 15
London 15
Mountain View 15
Baghdad 14
Guangzhou 14
Guayaquil 14
Seoul 14
Denver 13
Montreal 13
Rome 13
Salvador 13
Cagliari 12
Hebei 12
Nairobi 12
San Francisco 12
Santo André 12
Stockholm 12
Amman 11
Ankara 11
Campo Grande 11
Chennai 11
Guarulhos 11
Izmir 11
Jiaxing 11
Jinan 11
Naples 11
Ribeirão Preto 11
Sarapul 11
The Dalles 11
Vienna 11
Andover 10
Bogotá 10
Buffalo 10
Campinas 10
Chicago 10
Franca 10
Mexico City 10
Montevideo 10
Ningbo 10
Ottawa 10
Poplar 10
Recife 10
Abidjan 9
Betim 9
Casablanca 9
Dhaka 9
Fortaleza 9
Goiânia 9
Haiphong 9
Totale 6.031
Salva come PNG Salva come JPEG
Nome #
A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesis 350
Both de novo synthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cells 189
Bedside ultrasonography (US), Echoscopy and US point of care as a new kind of stethoscope for Internal Medicine Departments: the training program of the Italian Internal Medicine Society (SIMI). 187
Jagged 1 is a major Notch ligand along cholangiocarcinoma development in mice and humans 181
INVECCHIAMENTO E SISTEMA ENDOCRINO.LA SOMATOPAUSA, LA ADRENOPAUSA, LE MALATTIE DELLA TIROIDE 175
HEPATOCELLULAR CARCINOMA DEVELOPMENT IN A PATIENT WITH HCV INFECTION AFTER ERADICATION WITH DIRECT-ACTING ANTIVIRAL AGENTS 175
Evaluation of EZH2 expression in hepatitis B patients 174
Characterization of focal liver lesions with contrast-enhanced ultrasound. 173
The burden of HIV-Associated neurocognitive disorder (HAND) in post-HAART era: Amultidisciplinary review of the literature 162
Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis 160
Targeted therapies in cholangiocarcinoma: emerging evidence from clinical trials 158
Long-term Clinical Outcomes of Splanchnic Vein Thrombosis Results of an International Registry 157
Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria phenotype in patients with splanchnic vein thrombosis. 154
Clinical pattern of celiac disease in a population residing in North Sardinia (Italy) 152
Clinical history of cancer-associated splanchnic vein thrombosis 150
Immune compatible cystine-functionalized superparamagnetic iron oxide nanoparticles as vascular contrast agents in ultrasonography 148
Asymptomatic and symptomatic deep venous thrombosis in hospitalized acutely ill medical patients: risk factors and therapeutic implications. 143
A Case of thyroid metastasis from pancreatic cancer: case report and literature review 143
Functionalized multiwalled carbon nanotubes as ultrasound contrast agents 143
Comparison of 2D Shear Wave Elastography and Transient Elastography in Non-Invasive Evaluation of Liver Fibrosis in Hepatitis C Virus-Related Chronic Liver Disease 139
Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice 136
Inhibition of HSF1 suppresses the growth of hepatocarcinoma cell lines in vitro and AKT-driven hepatocarcinogenesis in mice 134
Antithrombotic treatment of splanchnic vein thrombosis: Results of an international registry 132
Effect of Probiotic Use on Adverse Events in Adult Patients with Inflammatory Bowel Disease: a retrospective Cohort Study 132
Fitz-Hugh-Curtis-syndrome mimicking acute cholecystitis: value of new ultrasound findings in the differential diagnosis 131
Clinical presentation, diagnosis, and staging of cholangiocarcinoma 131
Methotrexate therapy is not associated with increased liver stiffness and significant liver fibrosis in rheumatoid arthritis patients: a cross-sectional controlled study with real-time two-dimensional shear wave elastography 131
Diagnostic features of real-time contrast-enhanced ultrasound in focal nodular hyperplasia of the liver 131
Experience of high frequency ultrasound in rare scalp pathology 128
Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular Hepatocellular Carcinoma 123
Focal nodular hyperplasia: new findings at Doppler ultrasonography 123
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 123
Changes in hepatocellular carcinoma aggressiveness characteristics with an increase in tumor diameter 122
Characteristics and outcome of anti‐hepatitis D virus positive patients with hepatocellular carcinoma 121
Comparing Survival of Perihilar Cholangiocarcinoma After R1 Resection Versus Palliative Chemotherapy for Unresected Localized Disease 119
Surgical treatment of chronic multivascular mesenteric ischemia in a patient with antiphospholipid syndrome, abdominal aortic aneurism, and renal cancer: when planning overwhelms complexity Ann Ital Chir. 2016 Dec 20;5. pii: S2239253X16026104. PMID: 27941240 119
Red Cell Distribution Width as a Predictor of Survival in Patients with Hepatocellular Carcinoma 118
HSF1 is a prognostic determinant and therapeutic target in intrahepatic cholangiocarcinoma 116
Common Variable Immunodeficiency and Selective IgA Deficiency: Focus on Autoimmune Manifestations and Their Pathogenesis 116
The safety of Sonovue® in abdominal applications: Retrospective analysis of 23188 investigations 115
Functionalized multiwalled carbon nanotubes as ultrasound contrast agents. 113
Prevalence and risk factors of moderate to severe hepatic steatosis in patients with rheumatoid arthritis: an ultrasonography cross-sectional case–control study 112
HCC: Identificazione e caratterizzazione ecografica 112
Low Rate of Intrahospital Deep Venous Thrombosis in Acutely Ill Medical Patients: Results From the AURELIO Study 111
Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry 110
Contrast-enhanced ultrasound Liver Imaging Reporting and Data System: Lights and shadows in hepatocellular carcinoma and cholangiocellular carcinoma diagnosis 105
Safety and efficacy of low-dose fondaparinux (1.5 mg) for the prevention of venous thromboembolism in acutely ill medical patients with renal impairment: the FONDAIR study 103
Diagnosis and management of hepatic focal nodular hyperplasia. Journal of Ultrasound 101
Sorafenib and locoregional treatment in patients with stage B and stage C HCC: Sardinian experience 101
Usefulness of ultrasound in the diagnosis of peritoneal tuberculosis 101
Trapianto di fegato 100
Contrast-enhanced ultrasonography features of extramedullary hematopoiesis presenting as a presacral mass: an update of the literature. 100
The impact of vascular and nonvascular findings on the noninvasive diagnosis of small hepatocellular carcinoma based on the EASL and AASLD criteria. 97
Contrast-enhanced ultrasound patterns of hepatocellular adenoma: an Italian multicenter experience 97
Renal hemodynamics and renoprotection 95
A nomogram-based prognostic model for advanced hepatocellular carcinoma patients treated with sorafenib: A multicenter study 94
Prothrombotic and inflammatory markers in elderly patients with non-alcoholic hepatic liver disease before and after weight loss: A pilot study 93
Surveillance as determinant of long-term survival in non-transplanted hepatocellular carcinoma patients 93
Ipertensione portale: aspetti eco-color-Doppler 92
Pathophysiological roles, molecular interactions and clinical implications of long non-coding RNA CCAT2 in human cancer 91
Inverse association between glucose‒6‒phosphate dehydrogenase deficiency and hepatocellular carcinoma 91
RASi therapy in the renal haemodynamic in the course of proteinuric chronic nephropathy 91
Doppler US and contrast-enhanced perfusional angiosonography in hepatocellular carcinoma 89
Surveillance for hepatocellular carcinoma with a 3-months interval in “extremely high-risk” patients does not further improve survival 88
Identification of clinical phenotypes and related survival in patients with large hccs 88
Usefulness of ultrasound in the diagnosis of peritoneal tuberculosis 87
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database 87
Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy 86
The changing scenario of hepatocellular carcinoma in Italy: an update 86
Gastrointestinal Ultrasound in Emergency Setting 86
Microplastics and nanoplastics in cardiovascular disease—a narrative review with worrying links 83
Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study 81
Predictors of non-transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection 80
SIUMB guidelines and recommendations for the correct use of ultrasound in the management of patients with focal liver disease 80
Fatty Acid Synthase Promotes Hepatocellular Carcinoma Growth via S-Phase Kinase-Associated Protein 2/p27KIP1 Regulation 79
linical pattern of celiac disease in a population residing in North Sardinia (Italy 79
Role of Lung Ultrasound in the Management of Patients with Suspected SARS-CoV-2 Infection in the Emergency Department 78
Monofocal hepatocellular carcinoma: How much does size matter? 77
SIUMB recommendations for focal pancreatic lesions 77
Surgical treatment of hepatocellular carcinoma in the era of COVID-19 pandemic: A comprehensive review of current recommendations 76
Fisica, tecnica e principi di applicazione dell'eco-Doppler in medicina 76
An ultrasound-based approach to jaundice from diagnosis to treatment 76
Non-invasive tools for the prediction of esophageal varices in cirrhosis: Can advanced ultrasound techniques spare endoscopy? 74
Transarterial Chemoembolization for Hepatocellular Carcinoma in Clinical Practice: Temporal Trends and Survival Outcomes of an Iterative Treatment 73
Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review 68
Pattern of macrovascular invasion in hepatocellular carcinoma 68
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 67
Infectious Pneumonia and Lung Ultrasound: A Review 66
Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced HCC: A real-life comparison with best supportive care 65
Subclinical hyperthyroidism: The cardiovascular point of view 62
Time-Varying mHAP-III Is the Most Accurate Predictor of Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization 60
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs 56
SIUMB recommendations on the use of ultrasound in neoplastic lesions of the gallbladder and extrahepatic biliary tract 29
High systemic inflammation response index and increased cardiovascular risk and mortality in MASLD: A prospective cohort study 24
C-reactive protein-triglyceride glucose index as a predictor of heart failure risk in adults with MASLD: a prospective cohort study 22
null 10
C-reactive protein-triglyceride glucose index as a predictor of heart failure risk in adults with MASLD: a prospective cohort study 8
null 5
Totale 10.513
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.984
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.984
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022309 0 14 2 5 4 4 20 13 24 13 68 142
2022/2023774 80 69 17 131 74 122 0 90 124 8 34 25
2023/2024326 35 14 11 13 38 18 13 43 2 5 25 109
2024/20252.942 43 50 139 90 153 100 176 532 1.044 411 121 83
2025/20264.398 203 1.033 611 625 441 221 593 105 183 220 135 28
2026/2027341 104 237 0 0 0 0 0 0 0 0 0 0
Totale 10.513